UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE

UTOPIA aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.

OUR FOCUS

  • DISEASE MODIFYING DRUGS
  • CROSS BORDER CON ARTIFICIAL INTELLIGENCE
  • MEDICAL DEVICES
  • DIAGNOSTIC TOOLS AND BIOMARKERS

OUR INVESTMENTS

  • Novavido Srl
  • PerFormS Srl 
  • Lighthouse Biotech Srl 
  • Drug Discovery and Clinic Srl
  • CaSRevolution Srl
  • T-One Therapeutics Srl

The promoting members

UTOPIA SIS S.p.A.

UTOPIA SOCIETA’ DI INVESTIMENTO SEMPLICE aims to carry out Seed and Series A operations in the Life Sciences sector, an industry with significant investment opportunities. In Italy, it is still relatively underrepresented and characterized by a gap in terms of VC investments compared to the leading countries of the European Union.

What is a SIS

SOCIETA’ DI INVESTIMENTO SEMPLICE (SIS) is a Venture Capital vehicle aimed at investing in start-ups and unlisted SMEs and subject to a subsidized regime.

 

Our Focus

I

DISEASE MODIFYING DRUGS

I

CROSS BORDER CON ARTIFICIAL INTELLIGENCE

I

MEDICAL DEVICES

I

DIAGNOSTIC TOOLS AND BIOMARKERS

Latest News

Video interview with PerFormS on Business24

Video interview with PerFormS on Business24

Watch the video of the interview given by Performs to the Business24 Startupper program. Episode aired on 09/10/2024 h. 21:15 on channel 410 of digital terrestrial, 824 of Sky and 422 tivùsat, Presented by: Katia Gangale

Utopia SIS invests 1.5 million euros in DDC

Utopia SIS invests 1.5 million euros in DDC

Drug Discovery & Clinic S.r.l. (DDC), a spin-off of the University of Turin dedicated to the development of a platform for the creation of potentially effective drugs for different oncological scenarios, namely leukemia and breast cancer. Utopia SIS, the...